A 28-year-old woman with recurrent episodes of muscle pain and weakness is found to have elevated serum lactate and pyruvate levels. Genetic testing reveals a mutation in the E1α subunit of pyruvate dehydrogenase complex. Which metabolic finding best distinguishes her condition from a deficiency of succinate dehydrogenase?

Explanation

## Distinguishing PDH Deficiency from Succinate Dehydrogenase (SDH) Deficiency ### Pyruvate Dehydrogenase Complex (PDH) Deficiency **Key Point:** PDH deficiency blocks the **entry point** of the TCA cycle. Pyruvate cannot be converted to acetyl-CoA, causing: - Accumulation of pyruvate upstream - Shunting of pyruvate to lactate via lactate dehydrogenase (LDH) - **Elevated pyruvate AND lactate** (lactic acidosis) - Reduced acetyl-CoA availability - Impaired energy production and NADH generation **High-Yield:** The hallmark is **elevated pyruvate and lactate with blocked TCA cycle entry** — this is the classic presentation of PDH deficiency. ### Succinate Dehydrogenase (SDH) Deficiency **Key Point:** SDH deficiency blocks an **intermediate step** within the TCA cycle (succinate → fumarate). The metabolic consequences are: - Accumulation of succinate and upstream intermediates (α-ketoglutarate, isocitrate, citrate) - **Normal pyruvate metabolism** (PDH still functions) - Pyruvate and lactate remain normal or only mildly elevated - Impaired FADH~2~ generation (SDH is Complex II of the electron transport chain) - Progressive accumulation of TCA intermediates ### Comparative Metabolic Profiles | Metabolic Parameter | PDH Deficiency | SDH Deficiency | | --- | --- | --- | | **Pyruvate** | ↑↑ Elevated | Normal or slightly ↑ | | **Lactate** | ↑↑ Elevated (lactic acidosis) | Normal or slightly ↑ | | **Citrate** | ↓ Low (blocked entry) | ↑ Elevated (blocked exit) | | **α-Ketoglutarate** | ↓ Low (blocked entry) | ↑ Elevated (blocked exit) | | **Succinate** | Normal | ↑↑ Markedly elevated | | **NADH** | ↓ Reduced | ↓ Reduced (but less than PDH) | | **FADH~2~** | Normal | ↓ Severely reduced | | **TCA Cycle Status** | Blocked at entry | Blocked at intermediate step | ### Pathophysiology Flowchart ```mermaid flowchart TD A[Glucose/Pyruvate]:::outcome --> B{PDH functional?}:::decision B -->|No - PDH deficiency| C[Pyruvate accumulates]:::outcome C --> D[Shunt to lactate]:::action D --> E[Elevated pyruvate + lactate<br/>Lactic acidosis]:::urgent E --> F[Impaired TCA entry<br/>Low citrate, α-KG]:::outcome B -->|Yes - PDH OK| G[Acetyl-CoA formed]:::outcome G --> H{SDH functional?}:::decision H -->|No - SDH deficiency| I[Succinate accumulates]:::outcome I --> J[TCA intermediates back up<br/>High citrate, α-KG, succinate]:::outcome J --> K[Pyruvate/lactate normal<br/>FADH2 deficiency]:::outcome H -->|Yes - SDH OK| L[Normal TCA flux]:::outcome ``` **Clinical Pearl:** PDH deficiency presents with **acute lactic acidosis** during metabolic stress (infection, exercise), whereas SDH deficiency presents with **progressive mitochondrial dysfunction** and may cause paragangliomas or pheochromocytomas (familial SDH mutations are associated with SDHB/C/D tumors). **Mnemonic:** **PDH = Pyruvate Pileup** — pyruvate and lactate accumulate because the entry gate to the TCA cycle is blocked. **SDH = Succinate Stuck** — succinate and upstream intermediates accumulate because an intermediate gate is blocked. ### Why This Distinguishes the Conditions The **elevated pyruvate AND lactate with impaired TCA cycle entry at the acetyl-CoA formation step** is pathognomonic for PDH deficiency. In SDH deficiency, pyruvate metabolism is normal, so pyruvate and lactate levels remain relatively normal — the blockade is downstream, not at the entry point.